Tags: airway inflammation, asthma action plan, asthma attack, asthma costs, asthma economic burden, asthma genetics, asthma guide, asthma inhalers, asthma symptoms, asthma treatment, asthma triggers, BDNF, Breztri, Carpe Diem, chronic disease, FUNanc1al, FunHealth Index, GLP-1, health and wellness, health economics, inhaled corticosteroids, lung health, medical innovation, Ozempic, rescue inhaler, respiratory health, semaglutide, semaglutide asthma, Trimbow, triple therapy inhaler, Wegovy